Edition:
United Kingdom

Indivior PLC (INDV.L)

INDV.L on London Stock Exchange

59.10GBp
23 Aug 2019
Change (% chg)

-1.58 (-2.60%)
Prev Close
60.68
Open
61.56
Day's High
61.56
Day's Low
58.64
Volume
1,674,688
Avg. Vol
5,278,735
52-wk High
278.10
52-wk Low
20.98

Latest Key Developments (Source: Significant Developments)

Indivior PLC Says Howard Pien Bought 50,000 Shares At $0.7359 Per Share On Aug 8
Friday, 9 Aug 2019 

Aug 9 (Reuters) - Indivior PLC ::HOWARD PIEN, CHAIR, BOUGHT 50,000 SHARES AT $0.746725 PER SHARE ON AUG 7; ACQUIRED 50,000 SHARES AT $0.7359 PER SHARE ON AUG 8.  Full Article

Indivior Announces Court Of Appeals Ruling On Indivior Patents
Monday, 15 Jul 2019 

July 15 (Reuters) - Indivior PLC ::COURT OF APPEALS RULES ON INDIVIOR PATENTS.WATSON/ACTAVIS REMAINS ENJOINED FROM LAUNCHING THEIR GENERIC BUPRENORPHINE/NALOXONE SUBLINGUAL FILM PRODUCT UNTIL EXPIRATION OF '514 PATENT.  Full Article

Indivior Says Case With U.S. DOJ Separate From That Of Reckitt
Thursday, 11 Jul 2019 

July 11 (Reuters) - Indivior PLC ::INDIVIOR PLC - INDIVIOR PROVIDES STATEMENT ON RB SETTLEMENT.INDIVIOR PLC - NOTES TODAY'S ANNOUNCEMENT OF RECKITT BENCKISER GROUP'S (RB) SETTLEMENT WITH VARIOUS US GOVERNMENT ENTITIES.INDIVIOR PLC - INDIVIOR PLC'S CASE WITH US DEPARTMENT OF JUSTICE (DOJ) IS SEPARATE FROM THAT OF RB.INDIVIOR PLC - INDIVIOR HAS NO ADDITIONAL OR NEW INFORMATION RELATED TO US DEPARTMENT OF JUSTICE MATTER.  Full Article

Scopia Capital Management Cuts Stake To 11.85% In Indivior - Filing
Friday, 17 May 2019 

May 17 (Reuters) - Indivior PLC ::SCOPIA CAPITAL MANAGEMENT CUTS STAKE TO 11.85 PERCENT FROM 12.95 PERCENT IN INDIVIOR PLC - FILING.  Full Article

Reckitt working toward resolving Indivior situation despite belief it's done nothing wrong - Chairman
Thursday, 9 May 2019 

May 9 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER CEO STANDS BY FULL YEAR 2019 FORECAST.RECKITT BENCKISER CHAIRMAN SAYS COMPANY HAS DONE NOTHING WRONG AND SEES NO EVIDENCE OF IMPROPRIETY BY GROUP EMPLOYEES REGARDING INDIVIOR SITUATION.RECKITT CHAIRMAN SAYS COMPANY IS WORKING TOWARD RESOLUTION OF SITUATION.  Full Article

Reckitt Benckiser executive comments
Thursday, 2 May 2019 

May 2 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER CEO SAYS DON'T EXPECT CONSISTENT 3-4 PERCENT LFL IN EVERY QUARTER OF YEAR.RECKITT BENCKISER CFO SAYS REASON FOR INDIVIOR-RELATED PROVISION WAS DUE TO UNCERTAINTIES AROUND INDEMNITY AND REIMBUSEMENT.  Full Article

Indivior Announces Launch Of Perseris For Treatment Of Schizophrenia In Adults
Wednesday, 27 Feb 2019 

Feb 27 (Reuters) - Indivior PLC ::INDIVIOR ANNOUNCES LAUNCH OF PERSERIS™ (RISPERIDONE) FOR THE TREATMENT OF SCHIZOPHRENIA IN ADULTS.INDIVIOR PLC - LAUNCH OF ONCE-MONTHLY PERSERIS (RISPERIDONE) FOR EXTENDED-RELEASE INJECTABLE SUSPENSION IN UNITED STATES.  Full Article

Indivior Launches PERSERIS In The U.S.
Wednesday, 27 Feb 2019 

Feb 27 (Reuters) - Indivior PLC ::INDIVIOR LAUNCHES PERSERIS (RISPERIDONE).ANNOUNCES LAUNCH OF PERSERIS (RISPERIDONE) FOR TREATMENT OF SCHIZOPHRENIA IN ADULTS.LAUNCH OF ONCE-MONTHLY PERSERIS FOR EXTENDED-RELEASE INJECTABLE SUSPENSION IN UNITED STATES.  Full Article

Indivior Says Sublocade New Drug Submissions Made In Australia And Europe
Thursday, 14 Feb 2019 

Feb 14 (Reuters) - Indivior PLC ::INDIVIOR PLC - SUBLOCADE NEW DRUG SUBMISSIONS MADE IN AUSTRALIA AND EUROPE.INDIVIOR PLC - SEES 2019 OPERATING EXPENSES (SG&A AND RESEARCH AND DEVELOPMENT COMBINED) OF APPROXIMATELY $440M TO $460M, EXCLUDING EXCEPTIONAL ITEMS.INDIVIOR PLC - SEES ABOUT $140M OF ACTUAL ADJUSTED. OPEXSAVINGS BY END OF FY 2019 VERSUS. FY 2017 BASELINE.INDIVIOR PLC - VOLUNTARILY REPAID $235M OF TERM LOANS; $243M REMAINS OUTSTANDING.INDIVIOR PLC - READY TO LAUNCH AUTHORIZED GENERIC OF BUPRENORPHINE/NALOXONE SUBLINGUAL FILM.INDIVIOR PLC - CONTINUE TO ASSERT INTELLECTUAL PROPERTY AGAINST ANDA FILERS.INDIVIOR PLC - TARGETING APPROPRIATE HCPS WITH HIGH VOLUME LAI PRACTICES FOR PERSERIS IN 2019.  Full Article

Indivior Says FY Net Revenue Down 8 Pct To $1.01 Bln
Thursday, 14 Feb 2019 

Feb 14 (Reuters) - Indivior PLC ::INDIVIOR PLC - FINAL RESULTS.INDIVIOR PLC - FY NET REVENUE OF $1,005M, A DECREASE OF 8% VERSUS PRIOR YEAR.INDIVIOR PLC - FY OPERATING PROFIT WAS $292M (FY 2017: $193M).INDIVIOR PLC - U.S. SUBOXONE FILM MARKET SHARE AVERAGED AND EXITED FY 2018 AT 53%..INDIVIOR- TO LAUNCH AUTHORIZED GENERIC OF SUBOXONE FILM UPON CONFIRMATION OF LAUNCH OF GENERIC BUPRENORPHINE/NALOXONE SUBLINGUAL FILM PRODUCTS.INDIVIOR PLC - IMPLEMENTED KEY ELEMENTS OF ITS CONTINGENCY PLAN TO HELP OFFSET SUBSTANTIAL AND MATERIAL NEAR-TERM IMPACT TO NET REVENUE.INDIVIOR PLC - INDIVIOR IS UNABLE TO PROVIDE FY 2019 NET REVENUE AND NET INCOME GUIDANCE AT THIS TIME.INDIVIOR PLC - SEES SUBLOCADE NET REVENUE OF $50M TO $70M FOR FY 2019.INDIVIOR PLC - SEES FY 2019 OPERATING EXPENSES (SG&A AND RESEARCH AND DEVELOPMENT COMBINED) OF APPROXIMATELY $440M TO $460M.INDIVIOR -INTENDS TO PROVIDE FY19 NET REVENUE, NET INCOME GUIDANCE ONCE TOTAL U.S. BUPRENORPHINE/NALOXONE SUBLINGUAL FILM MARKET DYNAMICS ARE CLEARER.INDIVIOR PLC - "AS WE ENTER FY 2019, WE ASSUME WE FACE IMMINENT "AT-RISK" LAUNCH OF GENERIC RIVALS TO SUBOXONE FILM IN U.S".INDIVIOR PLC - FY SUBLOCADE NET REVENUES WERE $12M, INCLUDING $7M IN Q4 2018.INDIVIOR - CONTINUES IN ADVANCED DISCUSSIONS WITH U.S. DEPARTMENT OF JUSTICE ABOUT A POSSIBLE RESOLUTION TO ITS INVESTIGATIONS.INDIVIOR PLC - AUTHORIZED GENERIC OF SUBOXONE FILM LAUNCH EXPECTED TO GENERATE AN AMOUNT OF NET REVENUE IN RANGE OF TENS OF U.S.$ MILLIONS.  Full Article

Indivior profit rises on slower-than-expected Suboxone market share loss

Drugmaker Indivior Plc reported a 14% rise in quarterly profit on Wednesday, as its best-selling opioid addiction drug Suboxone lost market share to generic rivals at a slower pace than the company's previous modelling had expected.